Andrew Chase, Catherine Bryant, Joannah Score, Claudia Haferlach, Vera Grossmann, Juliana Schwaab, Wolf-Karsten Hofmann, Andreas Reiter and Nicholas C.P. Cross (2013) “Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements”, Haematologica. Pavia, Italy, 98(3), pp. 404-408. doi: 10.3324/haematol.2012.067959.